[α−N-(2’succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[ε−N-(2’succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[ε−N-(2’succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr | |
---|---|
Trade Name | |
Orphan Indication | Breast cancer patients with brain metastases |
USA Market Approval | USA |
USA Designation Date | 2015-04-15 00:00:00 |
Sponsor | Angiochem, Inc.;201 President Kennedy, Montreal, Quebec H2X 3Y7; |